Trial Profile
A Prospective, Randomized, Double-Blind, Crossover Comparison Evaluating Compatibility and Safety of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Patients With Type 1 Diabetes (PRONTO-Pump)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin lispro (Primary)
- Indications Type 1 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms PRONTO-Pump
- Sponsors Eli Lilly and Company
- 13 Sep 2018 Status changed from active, no longer recruiting to completed.
- 26 Apr 2018 Status changed from recruiting to active, no longer recruiting.
- 01 Mar 2018 Status changed from not yet recruiting to recruiting.